Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs Norfolk Southern Corporation (NSC) Price & Performance

Citius Pharmaceuticals IncTrade
Norfolk Southern CorporationTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs Norfolk Southern Corporation — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Norfolk Southern Corporation trades at $333.85 (market cap $75.15B). The key difference: Norfolk Southern Corporation is far larger — about 3755.6× Citius Pharmaceuticals Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

CTXRNSC
Market Cap
$20.01M$75.15B
Sector
HealthTechnology
52-Week High
$1.82$350.66
52-Week Low
$0.48$272.35
Enterprise Value
$16.23M$90.70B
Dividend Yield
1.61%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About Norfolk Southern Corporation

Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.

Read more on NSC